Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields.
Costa FP, de Oliveira AC, Meirelles R, Machado MC, Zanesco T, Surjan R, Chammas MC, de Souza Rocha M, Morgan D, Cantor A, Zimmerman J, Brezovich I, Kuster N, Barbault A, Pasche B. · 2011
View Original AbstractThis study shows electromagnetic fields can be therapeutic for liver cancer when precisely modulated, proving EMF effects depend entirely on exposure parameters.
Plain English Summary
Researchers tested whether very low-level electromagnetic fields, delivered through a device placed in the mouth, could help treat advanced liver cancer (hepatocellular carcinoma) in 41 patients with limited treatment options. The treatment was safe and well-tolerated, with 34% of patients experiencing stable disease for more than 6 months and some showing partial tumor responses. This suggests that precisely modulated electromagnetic fields might offer a new therapeutic approach for certain cancers.
Why This Matters
This study represents a fascinating reversal in EMF research - instead of examining harm, it explores therapeutic potential. The reality is that electromagnetic fields can have profound biological effects, and this research demonstrates that when precisely controlled and targeted, these effects might be harnessed for healing rather than causing damage. What makes this particularly significant is the extremely low exposure levels used - far below what you encounter from cell phones or other wireless devices. The fact that patients with advanced liver cancer, who had exhausted conventional treatment options, showed measurable responses challenges us to think more nuancially about EMF exposure. The science demonstrates that frequency, modulation, and dosage matter enormously in determining biological outcomes.
Exposure Information
Specific exposure levels were not quantified in this study.
Study Details
The aim of this study is to investigate Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields.
A single-group, open-label, phase I/II study was performed to assess the safety and effectiveness of...
Treatment was well tolerated and there were no NCI grade 2, 3 or 4 toxicities. In all, 14 patients (...
Treatment with intrabuccally administered amplitude-modulated electromagnetic fields is safe, well tolerated, and shows evidence of antitumour effects in patients with advanced HCC.
Show BibTeX
@article{fp_2011_treatment_of_advanced_hepatocellular_1996,
author = {Costa FP and de Oliveira AC and Meirelles R and Machado MC and Zanesco T and Surjan R and Chammas MC and de Souza Rocha M and Morgan D and Cantor A and Zimmerman J and Brezovich I and Kuster N and Barbault A and Pasche B.},
title = {Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields.},
year = {2011},
url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188936/},
}